secwatch / observer
8-K filed November 10, 2022, 6:59 PM ET ticker SRXH CIK 0001471727
earnings confidence high sentiment negative materiality 0.65

Better Choice Q3 net sales $11.9M (-10% YoY); net loss $6.5M vs $3.5M

SRx Health Solutions, Inc.

2022-Q3 EPS reported -$0.51 revenue$45,394,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

SRx Health Solutions, Inc. reported third quarter ended September 30, 2022 results: revenue $ 11,865, net income $ (6,547), EPS $ (0.22).

Period
third quarter ended September 30, 2022
Revenue
$ 11,865
Net income
$ (6,547)
EPS
$ (0.22)
Result
reported results
Exact text from the filing
Better Choice Company Inc. Unaudited Consolidated Statements of Operations (Dollars in thousands, except share and per share amounts) Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Net sales $ 11,865 $ 13,200 $ 45,394 $ 35,019 Cost of goods sold 7,700 8,762 31,795 22,407 Gross profit 4,165 4,438 13,599 12,612 Operating expenses: Selling, general and administrative 10,007 7,745 25,771 21,397 Share-based compensation 562 660 2,454 3,517 Total operating expenses 10,569 8,405 28,225 24,914 Loss from operations (6,404) (3,967) (14,626) (12,302) Other (expense) income: Interest expense, net (142) (79) (324) (3,148) Gain on extinguishment of debt, net — — — 457 Change in fair value of warrant liabilities — 590 — 23,463 Total other (expense) income, net (142) 511 (324) 20,772 Net (loss) income before income taxes (6,546) (3,456) (14,950) 8,470 Income tax expense 1 — 4 — Net (loss) income available to common stockholders $ (6,547) $ (3,456) $ (14,954) $ 8,4
View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR
accession 0001471727-22-000092
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.